Paediatric

Abstract Three-dimensional printing (3DP) technology in pharmaceutical areas is leading to a significant change in controlled drug delivery and pharmaceutical...

Poorly water-soluble drugs present a significant challenge in the development of oral solid dosage forms (OSDs). In formulation development the...

JRS Pharma presented three posters at the 2024 PBP World Meeting in Vienna. This is the first poster: Introduction Multiparticulate...

Abstract Developing safe and effective formulations for the geriatric and pediatric population is a challenging task due to issues of...

Abstract Interest in minitablets (MTs) has grown exponentially over the last 20 years and especially the last decade, as evidenced...

Abstract The administration of medications to children has been a challenge for parents and caregivers for generations. Pharmaceutical companies have...

Abstract The pediatric population exhibits an important age-dependent heterogeneity in pharmacokinetics and pharmacodynamics parameters, resulting in differences in drug efficacy...

Abstract Carvedilol (CARV) is a blocker of α- and β- adrenergic receptors, used as an “off-label” treatment for cardiovascular diseases...

Abstract The incidence of Inborn Error of Intermediary Metabolism (IEiM) diseases may be low, yet collectively, they impact approximately 6–10%...

See the new book, edited by Mine Orlu, Fang Liu Provides a better understanding on the EMA reflection paper on pharmaceutical...